Douglas P. Boyd, PhD., Chief Executive Officer
Mr. Boyd is an internationally recognized physicist who has pioneered in the fields of Medical Imaging and Airport Security Imaging. While at Stanford University he conceived the first fan-beam, rotary Computed Tomography scanners using Xenon detector arrays which became the standard in the industry for 20 years. The fan beam CT patents were licensed to General Electric and sub-licensed worldwide. While Professor of Radiology (Physics) at the University of California, San Francisco, he developed the first scanning electron beam CT scanner (EBCT) and later founded Imatron Inc which commercialized EBCT and was the leader in cardiac CT imaging for 20 years until sold to General Electric in 2001. While at Imatron he worked on airport explosives detection and later founded Invision which was for many years the only certified Explosives Detection System (EDSS) in airports for many years for which Dr. Boyd was awarded the Conway Safe Skies Award in 1993. Invision was sold to General Electric,, and later Morpho/Safran and has recently shipped the 2000th unit . In 2008 he founded TSS to help introduce the next level of explosives detection technology. During these years, Dr. Boyd served on the boards of a number of small innovative high-tech companies, published more than100 technical papers and was awarded 26 US patents.
Hui Hu, Ph.D., Director
Mr. Hu has over thirty years of experience in the medical imaging industry, particularly in multinational, midsize and startup companies. He was a Senior Physicist at GE Healthcare where he designed several GE flagship products, including the LightSpeed (multi-slice ) CT scanner and received numerous awards. He is the Founder, President and CEO of Hinnovation, which was acquired by a Nasdaq listed company (Vital Images) in 2004. Since then, he has been entrepreneurs and investors of several innovative startups in both US and China. Dr. Hu has published extensively in world-class journals, two of his publications on multi-slice CT have been cited over 1400 time. Dr. Hu is an inventor of over forty US patents.
Samuel M. Song, Ph.D., Chief Technology Officer
Mr. Song received the Scientiae Baccalaureus, MS, and Ph.D. degrees from Massachusetts Institute of Technology, University of California, Los Angeles and University of Southern California, respectively, all in Electrical Engineering. He has over twenty-five years of industrial and academic research and development experience in imaging and image processing systems. Dr. Song has served on the faculty of the Department of Radiology at the University of California, San Francisco, and on the faulty of School of Electrical Engineering at Korea University, Seoul, Korea. Most recently, he served on the faculty of the College of Engineering, Seoul National University, Seoul,Korea, as an Associate and Full Professor. He has published over a hundred scientific papers in international journals and conference proceedings. Dr. Song holds a number of US patents and has several others pending.Dr. Song is a founding investor and director of TeleSecurity Sciences.
Michael D. Weil, M.D., Chief Medical Officer
Dr Weil is a developer of low-cost, healthcare devices for under-served regions and an innovator in low-energy, x-ray therapy of advanced cancers. He is a founder of Sirius Medicine, which licensed kilovoltage (kV) x-rayoptics to Siemens, and developed clinically validated, kVx-ray therapeutics, including contrast-enhanced radiotherapy (CERT), and radiation-based immunotherapy. He conducted the first clinical trials of kV radiosurgery, as well as kV-based immunotherapy, and has performed over 200 such procedures on patients. Dr. Weil has served on the faculty of the Departments of Radiation Oncology at the University of California, San Francisco and the University of Colorado. He has been the author and principal investigator of a dozen submitted clinical oncology trials. Dr. Weil holds five U.S. patents and several others pending.
Brian A. Chard, F.C.I.S., Chief Financial Officer and VP of Business Development
Mr Chard is a qualified Accountant and Company Secretary. Mr. Chard is a UK Citizen and is a Director of one of Imatrex's main stockholders, Global Secure Limited.He has many years experience in raising equity finance and was responsible for the financial management and control of the Belfry Property funds, a series of multi-million $ UK commercial property funds. His particular emphasis was the fund's corporate and property finance, compliance with the Bank of England's Prudential Regulation Authority requirements and investor liaison. Mr. Chard has been closely involved in the founding and financing of a number of successful start-up and early stage property development, investment and technology businesses.
Tai-Nang Huang, Ph.D
Mr. Huang serves as President of Anagen Therapeutics, Inc. Dr.Huang founded Linden Technologies, Inc. in May 2000 and also serves as its Chief Executive Officer and President. Dr. Huang also founded Linden Bioscience, Inc.in 2002 devoted to bringing the world's best medical technologies to the people of Taiwan.
Bernard M. Gordon
Mr. Gordon is a preeminent engineer and inventor. He holds more than 100 U.S.patents, many more worldwide, for breakthrough technologies including those related to analog to digital conversion, instant imaging CT scanning, the fetal heart monitor, and digital Doppler radar. He has often been called the “father” of modern analog-to-digital conversion for his many contributions to the communication and medical instrumentation technologies that help enrich our lives. He was awarded the National Medal of Technology by President Reagan in 1986, was elected to the National Academy of Engineering in 1991, and has received several honorary degrees. He has provided active leadership on several boards in the engineering, healthcare, and education areas, and is the former President and co-founder of Analogic Corporation, and founder and Chairman of the Board of Photo Diagnostic Systems, Inc., a leading company in the PET imaging market and a partner with Telesecurity Sciences in the development of new CT scanning equipment. He remains an active entrepreneurial innovator. He is Chairman Emeritus of the Lahey Clinic and of Tufts University.